A New Drug Treats Severe Multiple Sclerosis

The Food and Drug Administration (FDA) approved the first and only drug to treat patients with severe Multiple Sclerosis (MS). The severe condition is Primary Progressive Multiple Sclerosis (PPMS), which is a nervous system disease that harms the brain’s ability to communicate with the rest of the body. The new drug is called Ocrevus and can only be distributed directly into the patient’s veins by a health professional. Clinical trials tested the drug in patients with both MS and PPMS and found it helpful. Although Ocrevus doesn’t prevent PPMS from progressing more, it does slow patients’ worsening symptoms. For those with MS, the drug lowers relapse rates and disability.

Latest.

Rep. Tim Ryan (D-OH) isn't the most vocal cannabis advocate on the 2020 presidential campaign trail, but you shouldn't take that as a lack of support for marijuana legalization. Unlike many of the top contenders for the upcoming Democratic primaries, Ryan hasn't filed any of his own cannabis legalization bills.

Can we see some ID please?

You must be 19 years of age or older to enter.